Overview of Dr. Tullius
Brian Tullius, MD, based in Orlando, FL, is a specialist in Pediatric Hematology & Oncology with a subspecialty in Pediatric Hematologic Oncology. He completed his medical training with a residency in Pediatrics at UC Davis Health and fellowships in Pediatric Hematology/Oncology at Nationwide Children's Hospital/Ohio State University. His professional experience includes roles as Research Medical Director at AdventHealth for Children and Clinical Fellow at Nationwide Children's Hospital. His research contributions include several publications on natural killer cells and CRISPR gene editing. He leads a clinical trial focusing on natural killer cell infusions for high-risk acute myeloid leukemia in children and young adults.
Office
2501 N Orange Ave
Ste 589
Orlando, FL 32804Fax+1 407-303-1301
Education & Training
- Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Hematology/Oncology, 2020 - 2021
- Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Hematology/Oncology, 2017 - 2020
- University of California Davis HealthResidency, Pediatrics, 2014 - 2017
- Naval Aerospace Medical InstituteFlight Surgeon, 2009 - 2010
- Naval Medical Center (San Diego)Internship, Pediatrics, 2008 - 2009
- University of Nebraska College of MedicineClass of 2008
Certifications & Licensure
- FL State Medical License 2021 - 2025
- OH State Medical License 2017 - 2021
- CA State Medical License 2015 - 2019
- NE State Medical License 2010 - 2014
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
Publications & Presentations
PubMed
- 8 citationsKnockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibod...Md Faqrul Hasan, Amanda R Campbell, Tayler J Croom-Perez, Jeremiah L Oyer, Thomas A Dieffenthaller
Journal for Immunotherapy of Cancer. 2023-12-11 - 7 citationsNatural killer cells for antiviral therapy.Davey M Smith, Jolie R Schafer, Brian Tullius, Laura Witkam, Silke Paust
Science Translational Medicine. 2023-01-04 - 11 citationsCRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy.Ezgi Elmas, Noushin Saljoughian, Marcelo de Souza Fernandes Pereira, Brian P Tullius, Kinnari Sorathia
Frontiers in Oncology. 2022-01-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: